Pulmonx Corp — Director's Dealing 2023

Jun 3, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Pulmonx Corp (LUNG)
CIK: 0001127537
Period of Report: 2023-06-01

Reporting Person: Lehman David Aaron (General Counsel)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-06-01	Common Stock	S	399	$11.48	Disposed	160797	Direct
2023-06-01	Common Stock	S	701	$11.48	Disposed	160096	Direct
2023-06-01	Common Stock	S	2676	$11.48	Disposed	157420	Direct

Footnotes

F1: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units (the "RSUs") granted on June 1, 2021.

F2: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 1, 2022.

F3: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 1, 2023.